Yahoo Web Search

Search results

1. • 

     Novavax Stock Just Tripled. Is It Too Late to Buy?

     The Motley Fool via AOL· 5 hours ago

     Novavax launched a cost-cutting plan and made significant progress in reducing research and development and general expenses by more than $500 million...

2. • Aptevo Therapeutics Presenting at The Protein & Antibody Engineering Summit, Boston, MA

     Digital Journal· 1 day ago

     ...initiation, enrollment and maintenance of patients, and the completion of clinical trials, the availability and timing of data from ongoing clinical trials, the trial design includes combination therapies that may make it difficult to accurately ascertain the benefits of APVO436, expectations...

3. • 

     Fact checking claims about vaccines as new COVID-19 variant emerges

     Kentucky Lantern via Yahoo News· 5 hours ago

     In the last month, new COVID-19 variants — known as FLiRT and part of the omicron family — emerged...

4. • NanoViricides Has Filed its Quarterly Report

     The Sacramento Bee· 4 hours ago

     SHELTON, CT / ACCESSWIRE / May 15, 2024 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a global leader in broad-spectrum antiviral nanomedicines, reports that it has filed its Quarterly ...

5. • 

     Is This a Setback for Moderna?

     Motley Fool via Yahoo Finance· 1 day ago

     But there's room for more than one, and Moderna may even excel thanks to a couple of factors. The biotech's candidate wasn't linked to any cases of...

6. • 

     Moderna and OpenAI Are Teaming Up, but Does That Make the Stock a Buy?

     Motley Fool via Yahoo Finance· 3 days ago

     And, at a time when its coronavirus vaccine revenue is no longer enough to make the stock as...

7. • 

     1 No-Brainer Growth Stock to Buy and Hold | The Motley Fool

     The Motley Fool· 4 days ago

     All of these superlatives (and more) describe Eli Lilly's (LLY -1.50%) performance in recent years...

8. • 

     Lula’s progress plan for Brazil: A year on

     Pharmaceutical Technology via Yahoo Finance· 2 days ago

     Still he says the handling of the coronavirus in Brazil demonstrated its control was only possible due to technology transfer negotiations among national...

9. • 

     Mers outbreak in Saudi Arabia puts health experts on high alert

     The Telegraph via Yahoo News· 5 days ago

     Health agencies are racing to determine the origins of a Mers outbreak in Saudi Arabia, after three...

10. • 

      AstraZeneca withdraws Covid-19 vaccine, citing low demand

      CNN Business via AOL· 7 days ago

      AstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...